6 Related NICE guidance
Details are correct at the time of publication. Further information is available on the NICE website.
-
Rituximab for aggressive non-Hodgkin's lymphoma. NICE technology appraisal guidance 65 (2003).
-
Improving outcomes in haematological cancers. NICE cancer service guidance (2003).